Imperial Capital Boosts Price Target on Dick's (DKS); 'Best-of-Breed'
Tweet
Share
E-mailGet Alerts DKS Hot Sheet
Price: $238.57 +2.41%
Rating Summary:
28 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
28 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Imperial Capital raised its price target on Outperform-rated Dick's Sporting Goods (NYSE: DKS) from $55 to $60 following 1Q13 results.
Analyst Lee Giordano said "We consider Dick's a best-of-breed retailer with talented management, an impressive track record of strong financial performance, and significant organic growth potential. We believe Dick’s market position and size as a leading big-box sporting goods retailer provides it with a sustainable competitive advantage offering one of the broadest and deepest assortments of leading brands, as well as a robust private brand/label offering."
The firm maintained 2013 and 2014 EPS estimates of $2.86 (+13%) and $3.33 (+17%).
For an analyst ratings summary and ratings history on Dick's Sporting Goods click here. For more ratings news on Dick's Sporting Goods click here.
Shares of Dick's Sporting Goods closed at $52.45 yesterday.
Analyst Lee Giordano said "We consider Dick's a best-of-breed retailer with talented management, an impressive track record of strong financial performance, and significant organic growth potential. We believe Dick’s market position and size as a leading big-box sporting goods retailer provides it with a sustainable competitive advantage offering one of the broadest and deepest assortments of leading brands, as well as a robust private brand/label offering."
The firm maintained 2013 and 2014 EPS estimates of $2.86 (+13%) and $3.33 (+17%).
For an analyst ratings summary and ratings history on Dick's Sporting Goods click here. For more ratings news on Dick's Sporting Goods click here.
Shares of Dick's Sporting Goods closed at $52.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
